ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Exelixis, NBE join forces for discovery and development of ADCs for cancer
September 24, 2020Exelixis and NBE-Therapeutics announced a partnership to discover and develop multiple antibody-drug conjugates (ADCs) for oncology applications by leveraging NBE’s unique expertise and proprietary platforms in ADC discovery, including site-specific ... -
Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)
January 24, 2019Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of services for new biological entities.... -
NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S
July 04, 2018NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 million extension of the Series B round. Together with an earlier CHF 20 million series B fin
Pharma Sources Insight January 2025
